Wells Fargo’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-400
| Closed | -$3.99K | – | 7106 |
|
|
2024
Q3 | $3.99K | Hold |
400
| – | – | ﹤0.01% | 5956 |
|
|
2024
Q2 | $8.92K | Sell |
400
-921
| -70% | -$28.5K | ﹤0.01% | 5777 |
|
|
2024
Q1 | $77.6K | Sell |
1,321
-50
| -4% | -$2.15K | ﹤0.01% | 5043 |
|
|
2023
Q4 | $30.4K | Buy |
1,371
+453
| +49% | +$6.83K | ﹤0.01% | 5466 |
|
|
2023
Q3 | $19.8K | Sell |
918
-3,941
| -81% | -$155K | ﹤0.01% | 5603 |
|
|
2023
Q2 | $328K | Buy |
4,859
+1,241
| +34% | +$513K | ﹤0.01% | 4260 |
|
|
2023
Q1 | $1.69M | Buy |
3,618
+2,645
| +272% | +$1.4M | ﹤0.01% | 3010 |
|
|
2022
Q4 | $390K | Buy |
973
+809
| +493% | +$310K | ﹤0.01% | 3782 |
|
|
2022
Q3 | $54K | Sell |
164
-33
| -17% | -$10.6K | ﹤0.01% | 4919 |
|
|
2022
Q2 | $51K | Sell |
197
-1,707
| -90% | -$436K | ﹤0.01% | 5006 |
|
|
2022
Q1 | $572K | Sell |
1,904
-1,069
| -36% | -$373K | ﹤0.01% | 4316 |
|
|
2021
Q4 | $1.05M | Sell |
2,973
-771
| -21% | -$240K | ﹤0.01% | 4062 |
|
|
2021
Q3 | $957K | Sell |
3,744
-672
| -15% | -$238K | ﹤0.01% | 4278 |
|
|
2021
Q2 | $2.94M | Sell |
4,416
-1,716
| -28% | -$989K | ﹤0.01% | 3351 |
|
|
2021
Q1 | $5.32M | Sell |
6,132
-119
| -2% | -$127K | ﹤0.01% | 2792 |
|
|
2020
Q4 | $5.8M | Sell |
6,251
-607
| -9% | -$638K | ﹤0.01% | 2604 |
|
|
2020
Q3 | $7.05M | Buy |
6,858
+605
| +10% | +$651K | ﹤0.01% | 2185 |
|
|
2020
Q2 | $6.34M | Buy |
6,253
+861
| +16% | +$799K | ﹤0.01% | 2244 |
|
|
2020
Q1 | $4.68M | Buy |
5,392
+399
| +8% | +$397K | ﹤0.01% | 2285 |
|
|
2019
Q4 | $5.35M | Sell |
4,993
-595
| -11% | -$607K | ﹤0.01% | 2504 |
|
|
2019
Q3 | $5.17M | Sell |
5,588
-8
| -0.1% | -$8.79K | ﹤0.01% | 2519 |
|
|
2019
Q2 | $6.32M | Sell |
5,596
-11,160
| -67% | -$12.2M | ﹤0.01% | 2359 |
|
|
2019
Q1 | $22.8M | Buy |
16,756
+13,742
| +456% | +$18.6M | 0.01% | 1369 |
|
|
2018
Q4 | $3.49M | Sell |
3,014
-117
| -4% | -$132K | ﹤0.01% | 2785 |
|
|
2018
Q3 | $4.75M | Sell |
3,131
-101
| -3% | -$156K | ﹤0.01% | 2687 |
|
|
2018
Q2 | $5.06M | Buy |
3,232
+613
| +23% | +$799K | ﹤0.01% | 2675 |
|
|
2018
Q1 | $3.03M | Sell |
2,619
-13
| -0.5% | -$17.1K | ﹤0.01% | 3040 |
|
|
2017
Q4 | $3.12M | Sell |
2,632
-1,557
| -37% | -$1.95M | ﹤0.01% | 3012 |
|
|
2017
Q3 | $5.63M | Buy |
4,189
+1,460
| +53% | +$1.54M | ﹤0.01% | 2416 |
|
|
2017
Q2 | $2.2M | Buy |
2,729
+248
| +10% | +$173K | ﹤0.01% | 3143 |
|
|
2017
Q1 | $1.53M | Buy |
2,481
+557
| +29% | +$339K | ﹤0.01% | 3421 |
|
|
2016
Q4 | $1.03M | Buy |
1,924
+469
| +32% | +$234K | ﹤0.01% | 3668 |
|
|
2016
Q3 | $753K | Buy |
1,455
+595
| +69% | +$280K | ﹤0.01% | 3698 |
|
|
2016
Q2 | $353K | Sell |
860
-291
| -25% | -$133K | ﹤0.01% | 4103 |
|
|
2016
Q1 | $612K | Buy |
1,151
+443
| +63% | +$221K | ﹤0.01% | 3744 |
|
|
2015
Q4 | $540K | Sell |
708
-215
| -23% | -$143K | ﹤0.01% | 3878 |
|
|
2015
Q3 | $506K | Buy |
923
+264
| +40% | +$160K | ﹤0.01% | 3942 |
|
|
2015
Q2 | $387K | Buy |
659
+604
| +1,098% | +$351K | ﹤0.01% | 4244 |
|
|
2015
Q1 | $44K | Buy |
+55
| New | +$42.6K | ﹤0.01% | 5067 |
|
Other funds holding KYNB
AC
6CM
Wells Fargo's KYNB Position: Q4 2024 in Review
Wells Fargo sold out of Kyntra Bio (KYNB) in Q4 2024, closing a stake of 400 shares — an estimated $3.99K sold.
Wells Fargo first reported a position in KYNB in Q1 2015 and held it in 39 quarters. The position peaked at $22.8M in Q1 2019. 68 funds tracked by Wall St. Rank hold KYNB as of Q4 2024.
- Wells Fargo reported no remaining Kyntra Bio position as of Q4 2024 after selling out during the quarter.
- Wells Fargo sold 400 Kyntra Bio shares in Q4 2024, an estimated $3.99K.
- Wells Fargo first reported a position in Kyntra Bio in Q1 2015 and held it in 39 quarters.
- Wells Fargo's Kyntra Bio position peaked at $22.8M in Q1 2019.
- 68 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2024.
Based on Wells Fargo's 13F filing for Q4 2024, filed 13 Feb 2025.